GDF11 administration in HFD mice significantly reduced NAFLD activity score (NAS), FBS, insulin level, lipid content and the expression of some genes involved in gluconeogenesis.7 The gene discussed is GDF11; the disease is metabolic dysfunction-associated steatotic liver disease.